Cari Meisel

Cari Meisel

Company: NanoTomer

Job title: Director of Research & Development


Simultaneous Treatment of Primary Solid Tumors, Metastatic Sites, & Tumor-draining Lymph Nodes Using a Non-traditional ADC to Target High Endothelial Venules 5:00 pm

Overview of HEVs as a novel, non-traditional target with a unique mechanism of action and strong therapeutic potential Evaluating concerns about off-target binding and toxicity Discussion of challenges and benefits of developing an IgM-format ADCRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.